In pediatric rheumatologic disease, methotrexate leads to mildly changed bloodwork on the second day after administration

Pediatr Rheumatol Online J. 2022 Apr 7;20(1):23. doi: 10.1186/s12969-022-00685-8.

Authors

Boris Hugle¹, Nadine Fischer², Johannes-Peter Haas²

Affiliations

¹ German Center for Pediatric Rheumatology, Garmisch-Partenkirchen, Gehfeldstrasse 24, 82467, Garmisch-Partenkirchen, Bavaria, Germany. huegle.boris@rheuma-kinderklinik.de.
² German Center for Pediatric Rheumatology, Garmisch-Partenkirchen, Gehfeldstrasse 24, 82467, Garmisch-Partenkirchen, Bavaria, Germany.

No abstract available

Publication types

Letter

MeSH terms

Arthritis, Rheumatoid*
Child
Humans
Methotrexate / therapeutic use
Rheumatic Diseases* / drug therapy

Substances

Methotrexate